|12.05.16 - Albany Medical Center Executive Courtney Burke Named to Trudeau Institute Board
SARANAC LAKE, New York – The Board of Trustees of the Trudeau Institute has announced the election of its newest member, Courtney Burke, senior vice president and chief strategy officer for Albany (N.Y) Medical Center.
Ms. Burke has more than 20 years of experience in health and disability policy. Since joining the medical center in July 2015 she has been responsible for developing and managing the implementation of the center’s strategic plan.
Ms. Burke previously served for two years as New York State’s deputy secretary for health under Gov. Andrew M. Cuomo, overseeing eight different health, disability, and aging-related agencies and offices. She was involved in launching the state’s successful health insurance exchange and helped secure both an $8 billion Medicaid waiver and a $100 million state innovation model award from the Centers for Medicare and Medicaid Services.
Prior to being named deputy secretary for health, Ms. Burke served as commissioner of the New York State Office for People with Developmental Disabilities, an agency of nearly 20,000 employees serving 126,000 New Yorkers. An expert in health and disability policy, she also served as director of the New York State Health Policy Research Center at the Rockefeller Institute of Government and as a senior Medicaid researcher, publishing and co-authoring numerous articles and research papers. She also served as the senior policy analyst at the Office of Advocate for Persons with Disabilities.
Ms. Burke earned a master’s in health policy and management from SUNY Albany’s School of Public Health. She currently serves on the boards of both the New York State Health Foundation and the State University of New York, having been appointed by Gov. Cuomo in September 2015 and June 2016, respectively.
Ms. Burke lives in Albany with her husband and two children.
About the Trudeau Institute
The Trudeau Institute is a nonprofit biomedical research center founded in 1884 by Dr. E.L. Trudeau. The Institute in 2016 has entered a renaissance, “Trudeau 3.0”, to leverage deep knowledge of immunity to foster the development of vaccines, treatments and cures for many life-threatening diseases, including cancer, tuberculosis and influenza. The Institute engages in R&D strategic partnerships and is supported by federal and state grants and contributions from individuals, private foundations and corporations. For further information about the Trudeau Institute, go to www.trudeauinstitute.org.